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Background: Human chorionic gonadotropin (hCG), lutropin, follitropin, and 
thyrotropin act as ap heterodimers to control reproduction and thyroid function. 
The a and p subunits of these proteins are divided into three loops (al ,a2,a3; 
pi $2$3) by cysteine knots and the heterodimer is stabilized by 20 P-subunit 
residues wrapped around a2 like a seatbelt. Understanding how these 
hormones interact with their receptors, a matter of considerable dispute, would 
facilitate design of pro- and anti-fertility agents. 
Results: By swapping a2 for p2 and vice versa and, in some cases, adding an 
amino-terminal coiled-coil dimerization domain, we prepared homodimeric 
analogs that have the conformation found in each ‘half’ of hCG. Homodimers 
containing loops pi ,a2$3 and none, part, or all of the seatbelt stimulated signal 
transduction to the same extent as hCG, albeit with lower potency. Those 
containing al ,P2,a3 were inactive. 
Conclusions: The activities of homodimers containing the pl ,a2,P3 groove 
exceed those of other minimized analogs more than 100-l OOO-fold, 
suggesting this portion of the hormone forms the major receptor contact. The 
discovery that glycoprotein hormone heterodimers can be converted to 
functional homodimers supports the proposal that this protein family evolved 
from an active homodimeric ancestor by gene duplication and acquisition of 
mutations to loop 2 that prevent homodimerization. This approach to protein 
minimization should be applicable to other proteins composed of 
architecturally related subunits, including those that might have arisen by 
gene duplication. 
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Introduction 
The glycoprotein hormones lutropin (LH), follitropin 
(FSH), and thyrotropin (TSH) control the functions of 
the ovaries, testes, and thyroid. Humans have two 
lutropins, hLH, an anterior. pituitary gland hormone 
essential for gonadal steroid secretion and ovulation, and 
chorionic gonadotropin (hCG), a closely related placental 
protein required for maintenance of pregnancy. Both 
hCG and hFSH, a hormone that promotes gamete devel- 
opment, are used extensively to enhance fertility. A 
better understanding of how the structure of these hor- 
mones controls their biological activities would facilitate 
the development of new approaches to fertility regula- 
tion. Based on the idea that minimized hCG analogs 
could be used to identify residues critical for activity, we 
have begun to tease the hormone apart. Here we describe 
the preparation and characterization of the first glycopro- 
tein hormone homodimers, minimized proteins that 
retain features topologically similar to either half of hCG. 
During these studies, we have also gained new insights 
into the parts of the glycoprotein hormone subunits that 
influence heterodimer formation. 
A high-resolution structure of hCG serves as the model for 
this cysteine-knot protein family [1,2]. All four glycopro- 
tein hormones are composed of an a subunit expressed 
from the same gene [3] and a unique p subunit that con- 
trols the biological specificity of the heterodimer [4]. Each 
subunit is divided into three elongated antiparallel loops 
(al,aZ,a3; fil,pZ,p3) by a cysteine knot (Figure 1). Loops 
1 and 3 of the same subunit are adjacent and located at the 
opposite end of the molecule from loop 2. In the het- 
erodimer the subunits are aligned ‘head-to-toe’ such that 
a2 is adjacent to pl,p3 and p2 is adjacent to al,a3 [1,2] 
(Figure 1). The p subunit contains 20 additional amino 
acids nicknamed the ‘seatbelt’ [l] that are wrapped 
around a2 to stabilize the heterodimer. Seatbelt residues 
also control the ability of hCG to distinguish between the 
LH, FSH, and TSH receptors [S-S], but it remains to be 
determined if this occurs through a direct receptor contact, 
an influence on hormone conformation, or both. 
Two radically different models (Figure Za,c) have been pro- 
posed to explain the interactions of the glycoprotein hor- 
mones with their receptors 19,101. Model 1 (Figure Za,b) 
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Diagram illustrating the relationship between the a and p subunits of all 
the glycoprotein hormones based on their relationship to hCG, the only 
family member for which a crystal structure has been obtained. The 
hCG heterodimer is formed by the combination of the a subunit (red) 
with the p subunit (green and black). Each subunit has a cysteine-knot 
motif (three yellow disulfide bonds) that divides them into three loops as 
shown. Loop 2 of the CL subunit (~2) contains an oligosaccharide (not 
represented) required for the full ability of hCG to elicit a biological 
response. The p subunit also contains 20 additional residues (black) 
that surround 132. The seatbelt is ‘latched’ to 81 through a disulfide 
bond (blue) to stabilize the heterodimer. The seatbelt also contains a 
small loop created by a disulfide bond (light blue) in its amino-terminal 
half. Positively and negatively charged residues in the small seatbelt 
loop influence lutropin and thyrotropin activity, respectively. The 
remaining disulfide bonds (light grey) are not essential for protein 
folding or for lupotropin activity. In the heterodimer, the amino-terminal 
ends of both hCG subunits overlap (shown, but not labeled on the 
diagram). 8 subunit residues carboxy-terminal of the seatbelt disulfide 
bond are not required for biological activity. Those from hCG, however, 
contribute to its long half-life in viva. 
suggests the groove between loops a2 and plJ33 makes 
the primary receptor contact and the seatbelt controls 
hormone specificity through its influence on subunit inter- 
action and the shape of the /3l,aZ$3 groove [9]. In con- 
trast, Model 2 (Figure Zc) postulates LH receptor contacts 
involve the a subunit carboxyl terminus, parts of PZ, and 
parts of the seatbelt, but not the /3l,aZ,p3 groove [lo]. In 
the second model the influence of the seatbelt on 
hormone specificity is mediated through its interaction 
with the receptor. 
We assumed these models could be distinguished by mon- 
itoring the activities of ‘minimized’ hCG analogs lacking 
parts of the hormone considered essential in each. Molecu- 
lar simulations based on the structure of hCG [ 11 suggested 
that a/p subunit chimeras prepared by substituting 
p subunit loop 2 with a2 should form symmetrical homod- 
imers lacking loops al,/%?,~~3 and the ~1 subunit carboxyl 
terminus. These analogs, termed cBABS for their compo- 
nents (hCG, Pl,aZ,/33, seatbelt), would contain two copies 
of loops pl,a2$3 and the seatbelt (Figures 3,4). These 
simulations also suggested that the conformations of 
pl,aZ,p3 and seatbelt would be similar to those in hCG. 
Model 1 suggested that the cBABS homodimer could 
interact with LH receptors through either of its two 
pl,aZ,p3 grooves. However, one of the two a2 oligosaccha- 
rides present in cBABS would make an inappropriate 
contact with the carboxy-terminal portion of the LH recep- 
tor extracellular domain to inhibit receptor interaction 
(Figures Zd, 4f, arrow). Thus, Model 1 also suggested that 
a related homodimer lacking the a2 oligosaccharide 
(cBABSGa2) would be substantially more active. Model 2 
predicted that both cBABS homodimers would be inactive. 
This is because they lack the a subunit carboxyl terminus 
and loop @2, two portions of the hormone previously postu- 
lated to form essential receptor contacts, and they contain a 
second copy of the seatbelt within the hormone-receptor 
interface, a feature expected to disrupt binding. 
Designing homodimers lacking the seatbelt required a 
strategy to mimic the roles this portion of the hormone has 
in subunit combination and dimer stability [ 111. The appar- 
ent proximity of the amino-terminal ends of the subunits in 
hCG [1,2] and cBABS homodimers suggested the functions 
of the seatbelt could be replaced by an amino-terminal 
coiled-coil dimerization domain that contained a cysteine 
capable of forming an intersubunit disulfide bond tether. 
Based on the results of immunological studies showing that 
the amino-terminal ends of hCG do not contact the LH 
receptor [9], we assumed that the presence of additional 
residues in this region would not prevent the dimer from 
interacting with LH receptors. Models of cBABS homod- 
imers suggested that the Ca and Cp carbons of Arg6 in 
each subunit would be approximately 6 A and 4 A apart, 
distances similar to those between the cysteines in a typical 
disulfide bond. Therefore, we expected that replacing 
p subunit residues l-5 with the coiled-coil domain of yeast 
transcription factor GCN4 [12] would promote dimeriza- 
tion, and that changing Arg6 to cysteine would form a sta- 
bilizing intersubunit disulfide bond. This would enable 
us to prepare homodimers having the a subunit carboxyl 
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Figure 2 
Cartoon illustrating models of hCG-receptor 
interaction. (a,b) Model 1, in which the 
pl ,a2$3 groove is postulated to interact with 
the rim of a horseshoe-shaped extracellular 
domain of the receptor. Note that in this 
model the seatbelt and parts of al ,3 make 
only limited contacts with the receptor [91. 
Model 1 also suggests a relationship between 
the extracellular and transmembrane domains 
of the receptor. A sideview is shown in (a), 
and (b) illustrates a view from outside the cell 
towards the cell surface. (c) Model 2, in which 
the M subunit carboxyl terminus, seatbelt, and 
loop p2 are postulated to interact with the 
concave surface of a horseshoe-shaped 
extracellular domain of the receptor. Note that 
in this model the pl ,a2$3 groove does not 
contact the receptor [lo]. Model 2 makes no 
predictions about the location of the 
transmembrane domain or the orientation of 
hCG (i.e., it could be flipped top-to-bottom 
relative to how it is illustrated here). Cd) The 
interaction of cBABS with the receptor as 
predicted by Model 1. The view shown is from 
the outside the cell towards the cell surface 
and illustrates how cBABS homodimers 
would bind to the extracellular domain of the 
LH receptor. Note that one of the a2 
oligosaccharides (arrow) would be expected 
to make a steric contact with the carboxy- 
terminal portion of the receptor extracellular 
domain. Blue, LH receptor extracellular 
domain; orange, LH receptor transmembrane 
domain; red, a subunit or parts derived from 
a subunit; green, /3 subunit or parts derived 
from p subunit; asterisks in (b,d) show the 
location of amino termini. Oligosaccharides on 
the p subunit, M subunit loop 2 (a+$, a subunit 
loop 3, and the receptor are not depicted for 
purposes of clarity. Those on the p subunit 
and a3 would point away from the receptor in 
both models. 
(a) 
a,p amino termini 
(b) (d) 
1 cx Carboxyl 
\ h terminus 
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terminus in place of the seatbelt (GCN4-cBABAGa2, 
Figure 4c) or loops al,PZ,a3 and truncated seatbelt in 
place of loops pl,cQ,p3 and full-length seatbelt (GCNLC 
cABASt, Figure 4d). By comparing the activities of these 
homodimers with those containing loops ~l,aZ,~3 and the 
entire seatbelt (cBABSGaZ), we expected to distinguish 
between the functions of the ~l,a2,~3 groove, the cx 
subunat carboxyl terminus, and the seatbelt. Model 1 pre- 
dicted that the seatbelt was not required for receptor inter- 
action and that all homodimers containing loops pl&?,p3 
and no a2 oligosaccharide (i.e., cBABSGa2, GCNLC 
cBABS&&?, GCN4-cBABA&!!) would be active, albeit not 
necessarily with equal potency. According to Model 1, a 
homodimer lacking loops Pl,aZ,P3 (i.e., GCN4-cABASt) 
would not be active even though its design incorporated 
parts of the seatbelt thought to influence LH activity [6,13] 
and to recreate a heterodimer-specific epitope present in 
hCG [14]. Model 2 suggested that neither homodimer 
would interact with receptors because GCN4-cBABAGa2 
is missing the entire seatbelt and GCN4-cABASt is 
missing the a subunit carboxyl terminus. 
Results and discussion 
Preparation and characterization of minimized 
homodimeric analogs 
Vectors encoding the amino-acid sequences of cBABS, 
cBABS analogs, GCN4-cBABA&xZ, and GCN4-cABASt 
(Figure 3) were built using standard molecular biology 
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Sequences of hCG a and 8 subunits, cBABS, and several analogs disulfide bonds: cBABS and cBABSGa2, C23-C81, C26-C119, 
(using single-letter amino-acid code) aligned to illustrate components Cl 02-C109; dgBABS&2-Y37C, same as cBABS plus 37C-37C; 
thought to be structurally homologous. All analogs contain the hCG GCN4-cBABSFa2, C34-C34, C51 -Cl 09, C54-C147, 
8 subunit signal sequence (MEMFQGLLLLLLLSMGGTWA). Vertical Cl 30-C137; GCN4-cBABAGa2, C34-C34, C51 -Cl 09, C71 -C71; 
lines refer to the locations of the cysteine residues in the cysteine knot. GCN4-cABASt, C34-C34, C77-C105. Thus, GCN4-cBABAGa2 is 
Other disulfide bonds: a subunit, C7-C31, C59-C87; 8 subunit, expected to contain two intersubunit disulfide bonds (one at the end of 
C23-C72, C26-Cl10 (seatbelt latch), C93-Cl OO. Presumed the GCN4 domain and one between the cysteine knots). 
methods and expressed in COS-7 and Chinese hamster 
ovary (CHO) cell lines. All the proteins were secreted from 
the cells and readily detected using a sandwich immunoas- 
say [15]. Analogs predicted to form homodimers based on 
molecular modeling did so, as revealed by their sizes in 
Western blots (Figure 5) and activities in immunoassays 
(Tables 12). Because hCG has only a single copy of each 
epitope, hCG cannot be measured in sandwich immunoas- 
says employing the same antibody or antibodies to over- 
lapping epitopes for capture and detection. In contrast, the 
homodimers contain two copies of every portion of hCG 
from which they were derived and were readily detected 
using two molecules of the same antibody, or using anti- 
bodies to overlapping epitopes (Tables 12). Thus, cBABS 
and cBABS&? reacted with monoclonal antibodies having 
conformation-sensitive epitopes exclusively on j31, p3, 
and/or the seatbelt (Table 1). GCN4-cBABA reacted with 
antibodies to epitopes on pl and/or p3. GCN4-cABASt 
reacted with antibodies to al, ~3, or 82, including one 
(B109) that detects an hCG dimer-specific epitope created 
by the proximity of p2 and amino-terminal seatbelt 
residues [9,14,16] (Table 2). cBABS analogs were also rec- 
ognized by antibody Bll 1, an antibody to a conformation- 
specific epitope of hCG and the hCG /3 subunit that 
includes the terminal seatbelt disulfide bond and sur- 
rounding residues [16]. Recognition of cBABS analogs in 
Bll 1/lz51-B1 11 demonstrated that both seatbelt disulfide 
bonds were latched (Table 1). As expected, compounds 
that lack a seatbelt (i.e., GCN4-cBABAGa2), or that have 
only a single seatbelt (i.e., hCG or the hCG p subunit) 
were inactive in Bll l/iasI--Bl 11 sandwich immunoassays. 
Detection of GCN4-cABASt by an antibody that recog- 
nized a heterodimer-dependent conformation in hCG 
showed that the subunits of this homodimer appear to be 
aligned similar to their positions in the al,P2,a3 region of 
hCG. Attempts to study subunit organization in homo- 
dimers containing loops pl,a2$3 were less straightforward 
due to the lack of heterodimer-specific antibodies to this 
region of hCG. Most antibodies to hCG p subunit loops pl 
and p3 recognize a conformation that is present in the free 
p subunit as well as in the heterodimer. Recognition of 
cBABS and derivatives by antibodies to the pl and p3 
loops (e.g., B112) and to the seatbelt disulfide bond (e.g., 
Bill) showed loops pl and j33 folded as anticipated and 
that the seatbelt disulfide bond had formed. These mea- 
surements, however, did not prove that the seatbelts of 
these analogs were wrapped around a2. To test this possi- 
bility, we compared the stabilities of hCG and cBABS 
homodimers to urea-induced subunit dissociation. If both 
homodimer seatbelts were wrapped around ~2, we 
expected that the homodimers would be more stable than 
hCG, a heterodimer stabilized by only a single seatbelt. 
cBABS analogs were more stable than hCG in 10 M urea 
(Figure Sa, lanes 7-9), a strong indication that each of their 
seatbelts was wrapped around an a2 loop. The urea stabil- 
ity of GCN4-cABASt (Figure 5b, lanes 3,4), a homodimer 
that lacks the seatbelt but has the potential to form a 
single intersubunit disulfide bond at the carboxyl termi- 
nus of the GCN4 domain [la], showed it to be stabilized 
by an intersubunit disulfide bond. Thus, it seemed likely 
that this intersubunit disulfide bond would form in all 
GCN4-containing homodimers. Because this disulfide 
bond would also prevent the subunits of the 
GCN4-cBABSGa2 homodimer from dissociating in urea, 
we were unable to determine if the seatbelts of this latter 
analog had become wrapped around a2. 
These observations demonstrated that we had accom- 
plished our first goal, namely to prepare minimized 
. 
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Figure 4 
Ribbon diagrams of (a) crystal coordinates of 
hCG heterodimer, (b) model of cBABS 
homodimer, (c) model of GCN4-cBABASa2 
homodimer, Cd) model of GCN4-cABASt 
homodimer (red, a-subunit regions; green, 
P-subunit regions; GCN4 residues, blue). 
Brackets illustrate the locations of the 
pl ,a2$3 grooves of hCG and homodimeric 
analogs. In this view, the receptor would be 
located beneath the hormone. (e-h) Space- 
filled views of the surface believed to face the 
LH receptor [9,10] shown for (e) hCG, 
(f) cBABS, (g) GCN4-cBABAGo2, and 
(h) GCN4-cABASt. The views shown in 
these panels were obtained by rotating those 
of panels a-d 90 about the x axis. The color 
code is similar to that in (a-d). The 
oligosaccharides of the cx subunit have been 
added and colored yellow. (To minimize the 
complexity of the figure, the P-subunit 
oligosaccharides are not shown. In this 
orientation, they would be located behind the 
hormone and extend below the surface of the 
paper.) Rectangular areas outline the 
pl ,a2$3 grooves of hCG and analogs, the 
region of these proteins that we suggest 
interacts with the receptors [9]. Note that 
areas within rectangular areas are similar in 
hCG (e) and in the active homodimers 
cBABS (f) and cBABA (9). A circle outlines 
the region of hCG (e) estimated from the 
report of Jiang et al. [lo] to interact with the 
receptor. Note that the composition of this 
region differs substantially in active 
homodimers such as analogs of cBABS (f) 
and cBABA (g). The arrow in (f) indicates the 
location of the ~12 oligosaccharide of cBABS 
expected to hinder binding to the LH receptor. 
proteins that enabled us to study each ‘half of hCG sep- 
arately, with or without the seatbelt (Figure 4). The rela- 
tionship between the structures of cBABS (Figure 4b) 
and GCN4-cBABA (Figure 4c) and hCG can be seen by 
comparing the analogs with the left half of hCG shown in 
Figure 4a. The relationship between the structure of 
GCN4-cABASt (Figure 4d) and hCG can be seen by 
comparing the analog with the right half of hCG shown 
in Figure 4a. 
implications of these observations for subunit combination 
None of the natural glycoprotein hormone subunits form 
stable homodimers under physiological conditions. In 
contrast, when PZ was replaced by a2, only those hCG 
p subunit analogs lacking both a seatbelt and an amino- 
terminal dimerization domain failed to form homod- 
imers. Furthermore, cBABS analogs containing hCG 
loops pl,aZ,p3 and a seatbelt derived from hFSH also 
formed homodimers (data not shown), indicating that 
246 Chemistry & Biology 1998, Vol 5 No 5 
Fiaure 5 
(4 W 
Western blots illustrating the formation of homodimers by cBABS, 
GCN4-cBABA, GCN4-cABASt, and related analogs. (a) cBABS and 
related proteins contain pl ,a2$3 and were detected by radioiodinated 
antibody Bl 12 in Western blots. (b) GCN4-cABASt contains 
pl ,ct2,p3 and was detected in Western blots by radioiodinated 
antibody Al 13. 
dimerization was not limited to the presence of the hCG 
seatbelt. The propensity of cBABS analogs to dimerize, 
albeit some better than others, implies that PZ inhibits 
hCG p subunit dimerization and, most likely, dimeriza- 
tion of all glycoprotein hormone /3 subunits. Failure of 
the /3 subunits to dimerize could occur because they lack 
contacts between a2 and pl,p3 observed in the het- 
erodimer [1,2] and/or because they are prevented from 
dimerizing by inappropriate contacts between p2 and 
other parts of the p subunit. 
The a subunit might dimerize poorly because it lacks a 
strong dimerization domain, because it lacks contacts that 
occur in the heterodimer between PZ and al,a3, and/or 
because it lacks a seatbelt. Cells transfected with cDNAs 
of both cBABS and the human cx subunit secreted cBABS 
homodimers and cBABS/rx subunit heterodimers (Table 1). 
Table 1 
In the hCG a subunit/cBABS heterodimer, one copy of CL? 
becomes located adjacent to al and a3. Thus, there appear 
to be no bad contacts between these loops, making it 
unlikely that contacts between a2 and al,a3 prevent the 
a subunit from forming homodimers. 
The a2 oligosaccharide is important for hCG subunit 
combination [17]. Cells engineered to express hCG 
a subunit lacking this oligosaccharide secrete much less 
heterodimer than those expressing the native protein. 
Similarly, the a2 oligosaccharide appears to be important 
for cBABS dimerization. Analogs lacking this oligosaccha- 
ride were secreted primarily as monomers (Figure Sa). 
This included cBABSGa2 and dgBABSFaZ-Y37C, an 
analog in which all N-linked oligosaccharides have been 
removed and a cysteine has been added to permit forma- 
tion of an intersubunit disulfide bond. The finding that 
Antibody recognition of cBABS analogs containing /3l,a2$3 components (B112 capture). 
wr 
Analvte ~112/1251-~113 Bl 1 2/‘251-B109 Bl 1 2Pz51-Bl 11 Bl 1 2Pz51-Bl 12 Bll 1/‘251-B1 11 
hCG p subunit 9oi 171 -1261285 17,596 * 501 -77&262 -502 k 84 
hCG 43,218 i 2071 14,439 i 569 30,162? 127 97*148 -239 k 184 
cBABS 157i 192 -297 f 104 27,573 rf: 1025 14,271 + 139 25697 i- 1148 
cBABS + c( subunit 6,437 i 295 -3562110 26,007 + 773 1,008+174 1018+ 139 
GCN4-cBABSGa2 -839 i 289 27 + 293 35,482 f 1465 23,419 * 371 33,551 I241 2 
GCN4-cBABAGa2 375 f 388 264 k 233 268 + 505 24,357 i 949 -12211487 
Sandwich immunoassays employed B112 for capture and radiolabeled 
antibodies (specific activity, 50 uCi/ug) to known hCG epitopes 
[5,6,9,16] for detection. Antibody binding sites: Al 09/Al 13/A202, al 
and/or ct3; Bl 01, p2; Bi 09, hCG dimer-specific epitope containing 
parts of p2 and seatbelt; Bl 11, seatbelt and carboxy-terminal residues 
near Cysl 10; B112, p3. Al 13, Bl 01, and 6109 bind overlapping 
hCG epitopes. Thus, only homodimers are detected by 
Bl 1 1/‘251-B1 11, Bl 1 2Pz51-81 12, Al 1 3Pz51-Al 13, 
Al 1 3Pz51-Bl 01, and Al 1 3/t251-B1 09 sandwich immunoassays. 
Values are means (counts per minute) of triplicates minus the blank. 
Those greater than 1000 are significant (p ~0.05). It is clear from these 
data that cBABS can combine with the a subunit to form 
heterodimers. cBABS analogs and GCN4-cBABAGa2 did not bind 
Bl 01 (data not shown). 
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Table 2 
Antibody recognition of GCN4-cABASt containing al,P2,c~3 components (Al 13 capture). 
Antibody pair 
Analyte Al 1 3/lz51-A1 13 Al 1 3/‘251-B1 01 Al 13/“51-B109 Al 1 3/‘251-B1 12 
hCG -370 i 130 263k612 704 k 280 13418k1643 
GCN4-cABASt 4358 zk 1064 14307 f 441 2224 f 305 202 + 699 
These sandwich assays employed Al 13; conditions are the same as those reported in Table 1. GCN4-cABASt did not bind Bl 11 (data not shown). 
only a small amount of dgBABSGaZ-Y37C was secreted 
as a homodimer showed that the potential to form an 
intersubunit disulfide bond was not sufficient to drive 
efficient dimerization (Figure Sa). Amino-terminal addi- 
tion of a strong dimerization domain substantially 
increased the formation of dimers lacking the a2 
oligosaccharide and/or seatbelt (compare GCN4- 
cBABSFa2, GCN4-cBABAGa2, and GCN4-cABASt, 
Figure 5a,b). As discussed later, however, it is possible 
that some of the GCN4-cBABSGa2 homodimers are the 
equivalent of tethered monomers lacking the arrange- 
ment of the pl,aZ,p3 loops expected in cBABS or 
cBABSGa2 homodimers. 
Interactions of the homodimers with receptors 
As predicted by Model 1, cBABS and cBABSGa2 stimu- 
lated LH-receptor-mediated cyclic AMP accumulation 
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Biological activities of cBABS and cBABSGa2 in rat LH receptor 
signal transduction assays, showing the effect of hCG and these 
analogs on LH receptor signal transducton. Note that the amounts of 
cBABS, cBABSGa2, GCN4-cBABSSa2, and GCN4-cBABAGa2 
homodimers used in the assays shown in Figures 6-l 1 were 
determined by sandwich immunoassay using purified cBABS as a 
standard, and confirmed by Western blot analysis. 
cBABSF&?, had l-3% of the potency of hCG. cBABS was 
40-fold less active than cBABSGa2 even though it con- 
tains two copies of the a2 oligosaccharide, a structure 
known to potentiate the signal-transduction activity of 
hCG [18]. This suggested that one or both copies of this 
oligosaccharide reduced LH receptor interactions and 
confirmed the prediction made by Model 1 that remov- 
ing the a2 oligosaccharide would enhance the activity of 
the homodimer (see Figure Zd). This observation is also 
consistent with the idea that parts of the hormone 
become located in the cavity created by the horseshoe 
shape of the receptor’s extracellular domain [9]. The rel- 
ative activities of homodimer- and monomer-enriched 
fractions of cBABS&Q (Figure 7) suggested the receptor 
interacted with the homodimer, not the free subunit. 
Unfortunately, because cBABSGa2 was produced primar- 
ily as a monomer and because the monomer was not 
readily separated from the homodimer by size-exclusion 
chromatography, we were unable to prepare sufficient 




hCG or analog (nM) 
Chemistry & Biology 
LH signal transduction assays of hCG and fractions for cBABSGa2 
enriched in homodimer (quantified as dimer) and monomer (quantified 
as monomer). 
248 Chemistry & Biology 1998, Vol 5 No 5 
Figure 8 Figure 9 
GCN4-cBABAGa2 
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Chemistry & Biology 
Abilities of GCN4-cBABSSa2 and GCN4-cBABAGa2 to inhibit 
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Abilities of GCN4-cBABSGa2 and GCN4-cBABAGa2 to stimulate 
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The abilities of cBABS and cBABSGa2 to elicit signal 
transduction contradict the hypothesis that the a subunit 
carboxyl terminus is essential for receptor binding and sig- 
naling, an important tenet of Model 2 [lo]. Both cBABS 
and cBABSGa2 lack the a subunit carboxyl terminus, a 
five-residue sequence required for hCG function that had 
previously been implicated as a major receptor contact 
[4,19,20]. Chen et al. [19] were unable to detect receptor 
binding or signal transduction in response to an hCG 
analog lacking the a subunit carboxyl terminus. Indeed, 
relative to hCG, it appears from the data [19] that their 
truncated hCG analog was less active than cBABSG&?. We 
postulate that the low activity of hCG analogs lacking the 
a subunit carboxyl terminus is due primarily to the influ- 
ence of these five residues on hormone conformation, not 
elimination of a key receptor contact. This idea is sup- 
ported by the observation that removal of the a subunit 
carboxyl terminus improved the ability of the heterodimer 
to be recognized by antibodies that bind the free a subunit 
much better than hCG [9]. Nonetheless, because the 
activities of cBABS and cBABSGCXZ are lower than that of 
hCG, we cannot exclude the possibility that the a subunit 
carboxyl terminus makes some contribution to the receptor 
contact site. Model 1 suggests the a subunit carboxyl ter- 
minus is located near both the extracellular and transmem- 
brane domains where it could contact the receptor [9]. 
The GCN4-dimerization domain [12] was required for 
preparing homodimers lacking all or part of the seatbelt 
(i.e., cBABA and cABASt). As a ‘control’, we also added 
the GCN4 domain to cBABSGa2. Although GCN4- 
cBABSF2 dimerized much better than cBABSGa2 
(Figure Sa), it was less active. GCN4-cBABSGCXZ blocked 
binding of lasI-hCG to CHO cells expressing LH recep- 
tors with only 0.01% the potency of hCG (Figure 8). The 
potency of GCN4-cBABSGa2 in signal transduction 
assays was lo-fold lower than that of cBABSFa2 and 
approximately 0.1% that of hCG (Figure 9). This result is 
probably not related to an inappropriate contact between 
the GCN4 coiled-coil domain and the receptor because 
an analog of hCG containing similarly located coiled-coil 
domains of Fos and Jun had identical receptor binding 
and signal transduction activities as hCG (W.L., M.P.B., 
and W.R.M., unpublished observations). A more likely 
explanation for the lower activity of GCN4-cBABSGa2 is 
that it contained substantial amounts of inactive dimers 
consisting of two GCN4-cBABSGa2 monomers joined at 
their amino-terminal ends. This type of homodimer 
would be produced by formation of the seatbelt disulfide 
bond prior to subunit combination. If the seatbelt became 
latched prior to dimerization, it would not be wrapped 
around a2 to stabilize the pl,aZ,p3 groove. Instead, due 
to its location, the seatbelt would be expected to prevent 
loop a2 of one subunit from associating with loops fil,p3 
of the other subunit, thereby precluding formation of the 
pl,aZ,P3 groove. Premature formation of the seatbelt 
disulfide bond during expression of cBABSGa2 would 
explain the secretion of high amounts of monomer and 
low amounts of dimer into the culture media. However, 
premature closure of the seatbelt in GCN-I-cBABSSa2 
would not prevent the subunits from being drawn 
together by a dimerization domain and held together in 
an inactive form by an intersubunit disulfide bond. 
Unfortunately, we would not be able to distinguish teth- 
ered monomers from homodimers that contained two 
copies of a2 surrounded by a seatbelt because both would 
be recognized by the same antibodies in sandwich 
immunoassays, both would be the same size, and both 
would be stable in 10 M urea. 
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Abilities of GCN4-cBABSGcx2, GCN4-cBABAGo2, and hCG a and 
p subunits to stimulate cyclic AMP accumulation in CHO cells 
expressing human FSH and TSH receptors and in cells expressing rat 
LH receptors. 
An analog with both seatbelts replaced by the a subunit 
carboxyl terminus, GCN4-cBABAGa2, had similar activi- 
ties to GCN4-cBABSGa2 in receptor-binding and signal- 
transduction assays (Figures 8,9). The finding that 
GCN4-cBABAGa2 retains substantial signal transduction 
activity makes it highly unlikely that the seatbelt is respon- 
sible for the major interaction between the hormone and 
the receptor. Because it has lower activity than hCG, 
however, we cannot exclude the possibility that seatbelt 
residues participate in a receptor contact. The low activity 
of GCN4-cBABAFa2 relative to that of cBABSFa2 is most 
likely to be related to the fact that the seatbelt appears to 
be required to stabilize the pl,aZ,p3 groove. Unlike the 
structure of a2 in hCG [l,Z], the conformation of a2 in the 
free subunit is unconstrained [al]. In hCG, the conforma- 
tion of a2 is constrained by contacts it makes with residues 
in the seatbelt and parts of pl,p3. The shape of a2 is much 
less likely to be constrained in analogs that lack the seat- 
belt than it is in hCG, resulting in some loss of activity. 
All analogs containing loops pl,aZ,p3 were more active 
than the individual a or p subunits, that is, analogs con- 
taining single copies of al,aZ,a3 and a subunit carboxyl 
terminus or pl,/X?,p3, and the seatbelt (Figure 10). They 
were also more active than the analog containing two 
copies of al,PZ,a3, and the part of the seatbelt postulated 
to interact with LH receptors (GCN4-cABASt, Figure 11). 
Concentrations of hCG-based homodimers that elicited 
maximal LH receptor stimulation were only marginally 
active in signal-transduction assays employing CHO cell 
Figure 11 
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Activity of GCN4-cABASt in rat LH receptor signal transduction 
assays. 
lines expressing FSH or TSH receptors (GCN4- 
cBABSGa2; GCN4-cBABAGa2, Figure lo), which showed 
that the activities of the homodimers depended on an 
interaction with the LH receptor, not an influence of the 
homodimers on CHO cells perse. A tenfold higher concen- 
tration of these analogs elicited a partial FSH response 
(data not shown; these amounts not tested in TSH assays). 
As observed previously [5,7], analogs containing hCG 
loops Pl,aZ,P3 can interact with all three receptors, indi- 
cating that this part of the molecule has only a small influ- 
ence on receptor-binding specificity, as discussed later. 
Implications of these data for glycoprotein hormone 
receptor interaction 
Crystal structures are available for several hormone-recep- 
tor complexes [ZZ-241. Alanine scanning mutagenesis of 
residues within the contact site has shown that relatively 
few ligand and receptor residues participate in essential 
contacts. Replacing the sidechain of only one of these ‘hot 
spots’ with alanine usually results in loo-fold or more loss in 
potency [25,26]. Construction of homodimers from the 
hCG heterodimer involved exchanging entire loops of the 
hormone subunits, a procedure expected to have a much 
more dramatic effect on hormone structure than replace- 
ment of single amino-acid residue sidechains by alanine. 
Thus, the homodimers would retain substantial hormonal 
activity in LH-receptor-mediated signal-transduction assays 
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only if they retained much of the receptor contact site and if 
the contact site was similar in conformation to that in hCG. 
The findings that the cx subunit carboxyl terminus, loop 
j32, and seatbelt are not absolutely required for hormone 
activity argue strongly against the view of receptor binding 
outlined in Model 2 (Figure 2~). The observations that all 
analogs that have loops Bl,a2$3 were active and those 
that lack an oligosaccharide on the a2 loop were the most 
active support the view that residues in loops Bl,aZ,p3 
participate in essential receptor contacts, a prediction of 
Model 1 (Figure Za,b). The entire surface of B subunit 
loops 1 and 3 furthest from the a2 loop can be recognized 
by monoclonal antibodies that bind the hCG-receptor 
complex [ 14,271. Thus, this region of hCG does not partic- 
ipate in receptor contacts. The only remaining surface 
common to hCG and all active homodimers available for 
participating in receptor contacts includes the end of the 
a2 loop and nearby residues in loops Bl and B3. Surfaces 
of hCG expected to contact the LH receptor in Models 1 
and 2 are shown as rectangles and ovals, respectively, in 
Figure 4. Those parts shown within the rectangles (i.e., 
residues of a2 and Bl$3 postulated in Model 1) are con- 
served in all the active molecules (Figure 4e-g). Those 
shown within the ovals are not conserved and, therefore, 
not expected to form a key receptor contact. 
At only l-3% the activity of hCG, the potency of 
cBABSG& might appear low. However, it is equal to or 
greater than that of many lutropins in ‘cross species’ assays 
[28], more than lOO-lOOO-fold greater than that of the 
most active synthetic peptide fragment [29], and substan- 
tially greater than that of either free hormone subunit. 
The homodimers described here are ‘first generation’ 
minimized proteins. As has been the case with other mini- 
mized proteins [30], it should be possible to improve their 
activities using mutagenesis, a process that will provide 
further insights into the relationship between hormone 
structure and function. 
Several factors may contribute to the differences in the 
activity of hCG and the most potent homodimer, 
cBABS&Q. First, cBABSGa2 is larger than hCG (Figure 4), 
a consequence of the fact that it contains two seatbelts and 
two copies of Bl,~~2$3, the largest loops in hCG. Support 
for the idea that the difference in size might hinder receptor 
binding comes from the observation that reducing the size 
of the protein by removing the oligosaccharide from loop 2 
resulted in a 40-fold gain in potency (Figure 6). Second, it is 
possible that the conformation of the groove between loops 
Bl,aZ,B3 in hCG and cBABSGa2 may not be identical. 
Subtle differences in the conformations of lutropins are 
known to disrupt their abilities to interact with receptors 
[27]. Third, unlike most cysteine-knot proteins, glycopro- 
tein hormone dimers are stabilized by a seatbelt, not one or 
more intersubunit disulfide bond. Therefore, they may not 
be as rigid as some cysteine-knot proteins, for example, 
vascular endothelial growth factor (VEGF) [25]. Instead, 
glycoprotein hormone dimers may acquire two or more 
stable conformations similar to those of glial cell-derived 
neurotrophic factor (GDNF) 1311. Based on the abilities of 
some anti-hCG monoclonal antibodies to bind hormone- 
receptor complexes with greater affinity than the free 
hormone, we have suggested that the conformation of 
lutropins is altered during receptor binding [16,32]. The 
presence of two seatbelts in cBABSGa2 might have hin- 
dered its ability to undergo the conformational change, 
thereby reducing its ability to interact with LH receptors. 
Finally, it is conceivable that other parts of hCG missing in 
cBABSGa2 might also participate in receptor contacts that 
augment binding now known to be associated with loops 
Bl,a2$3. Because the contributions of multiple binding 
sites to the overall affinity of a ligand-receptor pair are 
usually cooperative, in combination with the binding 
energy due to loops Bl,a2$3, the additional contribution 
of even a weak contact might be sufficient to account for 
the full potency of hCG. 
Potential utility of the homodimers 
In addition to their interest for studies of hormone struc- 
ture and function, the homodimers are expected to have 
practical uses for eliciting immunological responses to par- 
ticular regions of hCG, a postulate that we have recently 
confirmed (P.H.E., G.J. Macdonald, and W.R.M., unpub- 
lished observations). Because these homodimer analogs 
retain selected epitopes, they might have potential thera- 
peutic uses in the development of site-specific responses 
such as those needed for a contraceptive vaccine. 
Implications of these data for the evolution of glycoprotein 
hormones 
The evolutionary origin of proteins is usually traced by 
sequence analysis [33]. This may not always be possible, 
however, particularly when sequences diverge quickly or 
when key intermediates are lost or unknown. The discov- 
ery that intersubunit chimeras form functional homod- 
imers provides the first biochemical support for the idea 
that both glycoprotein hormone subunits could have 
evolved from a common ancestor [34]. We envision that 
following gene duplication, mutations that prevented 
homodimer formation accumulated in both subunits 
(Figure 12). The finding that co-expression of cBABS and 
the a subunit led to formation of cBABS homodimers and 
cBABS/a heterodimers (Table 1) shows this might have 
occurred in a stepwise fashion wherein one gene product 
lost the ability to homodimerize before the other. Such a 
process might have created families typified by activins 
and inhibins [35] in which some (i.e., inhibin a subunit) 
but not all (i.e., activin B subunits) members have lost 
their abilities to form homodimers. As in the case of the 
inhibin/activin family, this process would have the poten- 
tial to create agonist and antagonist analogs. 
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We propose a model for pituitary glycoprotein hormone 
evolution (Figure 12) in which the simplest ancestral gly- 
coprotein hormone was a cysteine-knot protein homod- 
imer similar to BABA, a protein likely to be stabilized by a 
disulfide bond, or BABS, a protein stabilized by two seat- 
belts. Homodimers lacking a seatbelt or the a2 oligosac- 
charide would probably not have been formed without an 
amino-terminal dimerization domain (not diagrammed). 
Following gene duplication, gain (BABA) or loss (BABS) 
of the seatbelt, modification of loop 2 and reduction in the 
dimerization domain yielded subunits that formed het- 
erodimers, not homodimers. Reduced affinity of a dimer- 
ization domain (both pathways), changes to loop 2 
(P-pathway), or loss of the seatbelt (a-pathway) would 
have prevented homodimer formation. Intersubunit disul- 
fide bonds between the cx subunit and p subunit cysteine 
knots cross-link and stabilize hCG (M. Einstein and 
W.R.M., unpublished observations). Cys31, a component 
in the a subunit Cys7-Cys31 disulfide bond not required 
for subunit combination or hormone activity 1361, might 
be a vestige of a primordial intersubunit disulfide bond. 
Although this disulfide bond would increase dimer stabil- 
ity, it did not promote efficient dimerization of deglycosy- 
lated cBABS analogs such as cBABS&Q,/31Y37C 
(Figure 5a), and therefore would be unlikely to drive 
dimerization of progenitors. Efficient dimerization 
required specific subunit interactions, a function fulfilled 
here by GCN4 residues located in the region correspond- 
ing to the prohormone sequence found in most other cys- 
teine-knot proteins. Introduction of negatively charged 
residues into the seatbelt would have eliminated the need 
for portions of the dimerization domain found at the 
p subunit amino terminus of lutropins. Thus, amino-ter- 
minal p subunit residues are required for efficient forma- 
tion of lutropins [37,38], but not follitropins, thyrotropins, 
or lutropin analogs containing negatively charged seatbelts 
[38]. The findings that GCN4-cBABSGa2 and GCNLC- 
cBABAGa2 had similar activities (Figure 8,9) and that 
cBABS/cx heterodimers were active (not shown) suggest 
many of these changes could have accumulated without 
disrupting essential hormone functions. 
In the a-subunit pathway elimination of the ability of 
the a-subunit precursor to form stable homodimers 
might have involved reduction in the strength of the 
amino-terminal dimerization domain and/or loss of an 
intersubunit disulfide. The highly conserved cysteine 
corresponding to human a subunit Cys31 [4], a residue 
capable of participating in an intersubunit disulfide, 
might be a vestige of an early BABA-like homodimer 
that was stabilized by a disulfide. 
In the P-subunit pathway the seatbelt might have been 
introduced into a BABA-type subunit by ‘read-through’ of 
the termination codon, a process similar to that proposed 
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A model for glycoprotein hormone evolution. Following gene duplication, 
inhibitory determinants were introduced into the subunits that prevented 
them from forming homodimers. The resulting P-subunit gene appeared 
to be duplicated several times. Based on the abilities of P-subunit 
analogs to interact with all three receptors, we postulate that loops 1 and 
3 of the ancestral hormone were the most chemically similar to those of 
lutropins. However, this should not be taken to imply that the earliest 
hormones had the physiological activities of lutropins, a characteristic 
dependent on tissues that express the hormone receptors. Numbers 
identify loops. Red, portions of homodimers derived from hCG CL subunit; 
green, portions of homodimers derived from hCG p subunit; dark blue, 
amino-terminal half of seatbelt; brown or orange, carboxy-terminal half of 
seatbelt; light blue, FSH loops pl ,p3; pink, TSH loops pl ,p3. 
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evolution of the hCG p subunit [39]. The first and second 
seatbelt cysteines (Cys93, CyslOO, hCG p subunit num- 
bering) form a disulfide bond that creates the small seat- 
belt loop in all p subunits. Participation of Cys93 in the 
Cys93-CyslOO disulfide bond would have prevented it 
from forming a disulfide bond with the cysteine in loop 2, 
a process ‘reversed’ during design of GCN4-cABASt. 
p subunit specificity would have been achieved through 
subsequent gene duplication and divergence led to het- 
erodimers with LH, FSH, and TSH activity, a process ini- 
tially dominated by mutations in the seatbelt [5,6] and 
later involved changes in pl and/or p3 [7]. PZ does not 
appear to have a significant influence on receptor-binding 
specificity [5,7]. Therefore, it would be expected that 
changes to pl,p3, and the seatbelt would have the great- 
est influence on p subunit evolution. It is not yet possible 
to determine which p subunit evolved first. However, 
chimeras containing pl and p3 from hCG, but not FSH or 
TSH, interact well with all three receptors [5-8,401, an 
indication that fll and p3 of the primordial ancestor were 
more similar to those found in existing mammalian 
lutropins than those in mammalian follitropins or thy- 
rotropins. hCG-based analogs containing an LH/FSH 
seatbelt chimera have full LH activity [6], high FSH 
activity [6], and substantial TSH activity [7]. Thus, a 
progenitor p subunit containing this chimeric seatbelt 
could have interacted with all three receptors, eliminating 
the need for simultaneous duplication of the p subunit 
and receptor genes. 
Only a few changes would have been required to convert 
the activity of the progenitor p subunit intermediate into 
that associated with current mammalian p subunits. Fol- 
lowing the first P-subunit gene duplication, introduction 
of negative charges into the amino-terminal portion of the 
seatbelt region would have decreased LH activity [5,13], 
increased TSH activity [7], left FSH activity unchanged 
[13], and reduced the need for the amino terminus in 
subunit combination [38]. A second P-subunit gene dupli- 
cation followed by mutations in pl and p3 that separated 
FSH and TSH activities would account for the failure of 
chimeras containing TSH and FSH pl,j33 to interact with 
all three receptors. Subsequent mutations appear to have 
occurred in a region of the TSH seatbelt not important for 
TSH activity. This would account for the observations 
that TSH/FSH chimeras containing the FSH seatbelt 
interact well with TSH receptors but FSH/TSH chimeras 
containing the TSH seatbelt do not interact with FSH 
receptors [5]. The hCG p su units appear to have evolved b 
by duplication of the lutropin P-subunit precursor and 
read-through of the termination codon 1391. 
Significance 
In humans, repoductive and thyroid function are con- 
trolled in part by four glycoprotein hormones, human 
chorionic gonadotropin (hCG), lutropin, follitropin and 
thyrotropin, which act as ap heterodimers. We are 
interested in understanding how these hormones inter- 
act with their receptors. Here we describe the construc- 
tion and analysis of the first homodimeric glycoprotein 
hormone analogs, symmetrical proteins that have sub- 
stantial biological and immunological activity. These 
studies have yielded new insights into glycoprotein 
hormone subunit combination, receptor interaction, 
and potential evolutionary mechanisms. 
Although many of the homodimers are larger than hCG 
itself, they can be considered minimized proteins 
because they are derived only from parts of the 
hormone. Previous efforts to minimize these hormones 
have relied almost exclusively on the preparation of syn- 
thetic fragments, peptides active only at very high con- 
centrations (i.e., 10 PM-10 mM), if at all. The very low 
activity of these peptides has confounded identification 
of parts of the hormones that interact with their recep- 
tors. In contrast, the homodimers constructed in this 
study retain many key aspects of hormone conforma- 
tion, including some aspects known to depend on inter- 
actions between the two hCG subunits. The finding that 
all active homodimers contain the groove between 
a subunit loop 2 and p subunit loops 1 and 3 provides the 
first direct evidence that this portion of hCG (and pre- 
sumably other glycoprotein hormones) participates in 
the primary receptor contact. This region of the protein 
should now become the major focus of efforts to further 
dissect ligand-receptor interactions. The homodimer 
approach to protein minimization should be applicable 
to studies of other heterodimeric proteins that have 
similar architectures. 
Finally, hCG is known to be essential for human preg- 
nancy, an observation that has been the basis for wide- 
spread efforts to devise a contraceptive vaccine. A 
major difficulty in vaccine development is related to the 
similarity of hCG and lutropin (hLH). Most immuno- 
gens designed to raise neutralizing antibodies against 
hCG also elicit antibodies to hLH. The finding that the 
homodimers retain the structures from the parts of hCG 
from which they are derived should facilitate design of 
immunogens that elicit antisera capable of immunoneu- 
tralizing hCG but not cross-reacting with hLH. 
Materials and methods 
Modeling 
Homodimers were designed using coordinates from the crystal struc- 
ture of hCG [l] and the modeling package Sybyl (Tripos, St. Louis, 
MO). The cysteine knots in the subunits of cBABS, cBABA, and 
cABASt analogs were aligned with those of each hCG subunit. Both 
halves of each homodimer are nearly identical to one another and to the 
components of hCG from which they were derived (Figure 4a,b,e,f). The 
Co and C8 carbons of Arg6 in each subunit of these model homod- 
imers are approximately 6 A and 4 A apart, distances similar to those of 
cysteines in a disulfide bond. During design of GCN4containing 
homodimers, each Arg6 was converted to cysteine, the homodimers 
Research Paper Functional homodimeric glycoprotein hormones Moyle et al. 253 
joined by a CysG-Cys6 disulfide bond, and coordinates of amino-termi- 
nal residues deleted. The cysteine coordinates of a GCN4 homodimer 
that contains a carboxy-terminal disulfide bond [I 21 were aligned with 
the CysG-Cys6 disulfide bond of the homodimers. Merging the GCN4 
and homodimer coordinates led to structures typified by that shown in 
Figure 4c. During design of cABASt, we attempted to maintain the rela- 
tive positions of 82 and the amino-terminal portion of the seatbelt 
required to form the binding site for B109, an hCG heterodimer-spe- 
cific antibody [I 41. Simulations suggested this could be accomplished 
by replacing Val56 of j32 with cysteine and truncating the seatbelt at 
residue 98 to create two free adjacent cysteines (i.e., Cys56 of @2 and 
hCG seatbelt residue Cys93), which have the same potential to form a 
disulfide bond as a subunit residues Cys59 and Cys87. Analysis by 
PROCHECK [41] showed that the phi-psi bond angles of all models 
were in allowed regions. 
Homodimer expression 
Constructs driving the expression of cBABS and cBABA analogs 
(Figure 3) were prepared using standard cassette and PCR mutagen- 
esis methods, taking advantage of natural or previously introduced 
restriction-enzyme sites in the hCG p subunit cDNA 15,141. The 
codons for GCN4 and cABASt were entirely synthetic and prepared 
by Vent polymerase (New England Biolabs, Beverly, MA) fill-in of long 
overlapping oligonucleotides. All sequences were verified by dideoxy 
sequencing methods. Proteins were produced by expression in COS- 
7 and CHO cells using commercially available expression vectors 
(pSVL, Pharmacia, Piscataway, NJ; pCI, Promega, Madison, WI) and 
methods described previously [5]. BABS and ABASt analogs were 
immunoaffinity purified using anti-subunit monoclonal antibodies Bl 10 
(81 ,j33specific) or BlOl (j32specific) 1151 coupled to Affi-Gel Hz 
Hydrazide resin (BioRad, Hercules, CA) according to the manufactur- 
er’s directions. To prevent cross-contamination, each analog was puri- 
fied on a new resin. Final purification involved high-performance liquid 
chromatography (HPLC) gel filtration on 0.75 x 30 cm TSK 
G3000SW (TosoHaas, Philadelphia, PA) or 1 x 30 cm SuperoseG-HR 
(Pharmacia, Piscataway, NJ) columns. These resins only partially sepa- 
rated the cBABSGa2 homodimer from the monomer. cBABSSa2 
homodimer-enriched fractions used in Figure 7 contained material 
from the leading edge of the overlapping dimer/monomer peak and 
cBABSGa2-monomer-enriched fractions contained material from the 
peak and trailing edge. 
Homodimer purification and assay 
cBABS analogs were quantified by sandwich immunoassays employ- 
ing B112 for capture and radioiodinated B112 for detection using a 
purified cBABS standard whose concentration had been determined 
by amino-acid analysis at LSUMC Auxiliary Enterprises (Louisiana State 
University, New Orleans, LA). GCN4-cABASt was quantified by sand- 
wich immunoassays employing Al 13 for capture and radioiodinated 
A202 for detection using an hCG standard. Receptor binding and 
signal transduction assays were performed using 80,000-200,000 
CHO cells stably expressing LH, FSH, or TSH receptors [6,7]. hCG 
a and j3 subunit assays were performed in the presence of 3 pg of anti- 
hCG b or a subunit antibodies, respectively, to neutralize the hCG con- 
tamination of the subunit preparations. 
Assay reproducibility 
The ability of homodimers containing hCG loops 81 ,a2,b3 to stimulate 
signal transduction was seen in every assay in which it was tested (26 
assays) performed over a period of two years by three different individ- 
uals using several different preparations (R.V.M., Y.H., and Y.W.). It 
should be noted, however, that we observed maximal stimulation equal 
to that of hCG only in those assays employing material that had been 
purified from cell culture media. 
Note added in proof 
We call attention to the recent article by Li and Ford (Li, M.D. B Ford, J.J. 
(1998). A comprehensive evolutionary analysis based on nucleotide and 
amino acid sequences of the cr and p subunits of the glycoprotein 
hormone gene family. J fndocrinol. 156, 529-542) who suggest glyco- 
protein hormones evolved from a primordial ancestor more than 900 
million years ago, based on comparisons of nucleotide and amino-acid 
sequences of 58 01 and b subunits from piscine, amphibian, avian and 
mammalian species. Some of these organisms predate the appearance 
of vertebrates, the only animals in which function of these hormones has 
been clearly demonstrated. Sequence comparisons also suggest that 
lutropin-like p subunits predated those of follitropins and thyrotropins, a 
conclusion consistent with the model in Figure 12 reached on the basis 
of protein engineering. 
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